| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Shanghai MicroPort MedBot (Group) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$15.82 |
| 52 Week High | HK$25.10 |
| 52 Week Low | HK$9.68 |
| Beta | 1.06 |
| 1 Month Change | 35.45% |
| 3 Month Change | 17.19% |
| 1 Year Change | -20.50% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2252 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -0.1% | -0.1% | 4.8% |
| 1Y | -20.5% | -40.1% | 0.6% |
Return vs Industry: 2252 exceeded the Hong Kong Medical Equipment industry which returned -40.2% over the past year.
Return vs Market: 2252 underperformed the Hong Kong Market which returned -0.3% over the past year.
Price Volatility
| 2252 volatility | |
|---|---|
| 2252 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.4% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2252's share price has been volatile over the past 3 months.
Volatility Over Time: 2252's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 646 | Chao He | www.medbotsurgical.com |
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR’obot, a Mona Lisa robotic transperineal prostate biopsy system.
Shanghai MicroPort MedBot (Group) Co., Ltd. Fundamentals Summary
| 2252 fundamental statistics | |
|---|---|
| Market cap | HK$15.16b |
| Earnings (TTM) | -HK$1.09b |
| Revenue (TTM) | HK$113.12m |
134.1x
P/S Ratio-13.9x
P/E RatioIs 2252 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2252 income statement (TTM) | |
|---|---|
| Revenue | CN¥104.59m |
| Cost of Revenue | CN¥89.90m |
| Gross Profit | CN¥14.69m |
| Other Expenses | CN¥1.03b |
| Earnings | -CN¥1.01b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.06 |
| Gross Margin | 14.05% |
| Net Profit Margin | -967.74% |
| Debt/Equity Ratio | 94.8% |
How did 2252 perform over the long term?
See historical performance and comparison